The analysis aimed to explore the distribution of XRCC1 (rs1799782), CHEK2 (rs17879961), and XPD (rs238406) genotypes in a cohort of female breast cancer patients and their potential association with clinical characteristics and histopathological subtypes. This evidence concerns the gene ERCC2 and breast carcinoma.